What Is Braskem S.A. (BAK) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Braskem S.A. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.
What Do the Models Say About BAK?
0 of 13 models are currently active for BAK. See which stocks rank higher →
How Does BAK Rank in Chemicals?
Among 17 Chemicals stocks, BAK ranks #16 by Quality of Company score. CirclFi's QOC score of 5.8/10 evaluates 32 fundamental signals. A score of 5.8 reflects mixed fundamentals.
The Chemicals sector introduces analytical considerations specific to industrial enterprise businesses. For Braskem S.A., metrics like book-to-bill ratio provide important context that general-purpose valuation models may underweight.
Is BAK a Value Trap?
CirclFi's Value Trap algorithm assigns BAK a score of 9/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
0 of 13 models are active for Braskem S.A.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Braskem S.A. earns a quality score of 5.8/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BAK valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →